-The Telegraph New Delhi: The income tax department has allowed referral kickbacks paid to doctors by private hospitals, nursing homes and diagnostic centres and spending on advertisements by doctors as expenses despite such expenditure being disallowed and unethical, a parliamentary panel said on Thursday. The public accounts committee for the Union finance ministry's department of revenue has cited an audit that found that in 19 instances in eight states, income-tax officers had...

-The Indian Express The Department of Industrial Policy and Promotion (DIPP) and the NPPA are also documented as having given similar assurances in subsequent meetings. New Delhi: After the National Pharmaceutical Pricing Authority (NPPA) imposed price caps on coronary stents in February last year, the Prime Minister’s Office (PMO) is documented as having “indicated” to representatives of foreign medical device companies in a meeting that the Indian government has no plans to...

-The Telegraph New Delhi: A five-judge Supreme Court constitution bench on Wednesday ruled that parliamentary standing committee reports can be examined by courts for evidence evaluation, rejecting the Centre's argument that it would be a breach of parliamentary privileges and an encroachment into the domain of the legislature. The apex court, however, said "admissibility of a parliamentary committee report in evidence does not mean facts stated in the report stand proved", as...

-TheWire.in Why has India chosen the path of expanding medical insurance instead of a more comprehensive approach to health? The concern with rising inequities in access to medical care, rising out-of-pocket expenditures and unmet treatment needs have been addressed with yet another targeted medical insurance scheme for poor households. The idea of a targeted medical insurance is not new. Several southern states like Andhra Pradesh and Karnataka had introduced such schemes many...

-The Telegraph New Delhi: Doctors who receive gifts from Pharmaceutical Companies are more likely to prescribe expensive versions of medicines and more drugs per patient, a US study released on Wednesday suggested. The study is among the first to quantitatively measure the impacts of such gifts and challenges claims by sections of pharmaceutical industry executives that industry gifts are not intended to influence prescriptions doctors write. Health policy researchers who analysed prescription patterns...